Topic
Urologic Oncology
127 Podcasts • 16 Cases • 8 Courses on BackTable
Hear how experienced clinicians in Urologic Oncology approach day-to-day decision-making on BackTable. Learn from podcasts, cases, and courses curated by physician content creators. Get the BackTable app to follow this Topic and hear more of the conversations that matter to your practice.
Episode # 71 • 07 Jul 2026
Exploring PARP Inhibitor Combinations in Prostate Cancer
With multiple clinical trials evaluating PARP inhibitor combinations, how do clinicians determine the best approach for advanced prostate cancer? In this episode of BackTable Urology, Dr. Alan Tan is joined by Dr. Rana McKay and Dr. Emmanuel Antonarakis to discuss how evolving evidence, patient selection, timing, toxicity, and genetic testing are shaping the use of PARP inhibitor combinations in clinical practice.
This podcast is supported by an educational grant from Pfizer.
More on Urologic Oncology
Loading recent podcasts…
Tumor Board # 71
Jul 7, 2026
with Dr. Rana McKay, Dr. Emmanuel Antonarakis, Dr. Alan Tan
With multiple clinical trials evaluating PARP inhibitor combinations, how do clinicians determine the best approach for...
Urology # 313
Jun 30, 2026
with Dr. Kirsten Greene, Dr. Ruchika Talwar
Is pelvic lymph node dissection still necessary in the era of PSMA PET imaging? In this episode of BackTable Urology,...
650+ listens
Tumor Board # 69
Jun 25, 2026
with Meredith Donahue NP, Mary Dunn NP, Dr. Vignesh Packiam
How can clinics minimize toxicity and maximize outcomes in intravesical bladder cancer treatment? In this episode of...
60+ listens
Urology # 310
Jun 18, 2026
with Dr. Sunil Patel, Dr. Kristen Scarpato, Dr. Bogdana Schmidt
Why does up to 10% of bladder cancer pathology change on expert review, and what does that mean for your intermediate...
880+ listens
Urology # 314
Jul 7, 2026
with Dr. Rana McKay, Dr. Emmanuel Antonarakis, Dr. Alan Tan
With multiple clinical trials evaluating PARP inhibitor combinations, how do clinicians determine the best approach for...
Urology # 312
Jun 25, 2026
with Meredith Donahue NP, Mary Dunn NP, Dr. Vignesh Packiam
How can clinics minimize toxicity and maximize outcomes in intravesical bladder cancer treatment? In this episode of...
700+ listens
Tumor Board # 67
Jun 18, 2026
with Dr. Sunil Patel, Dr. Kristen Scarpato, Dr. Bogdana Schmidt
Why does up to 10% of bladder cancer pathology change on expert review, and what does that mean for your intermediate...
30+ listens
Urology # 308
Jun 11, 2026
with Dr. Kelly Bree, Meredith Donahue NP, Dr. Saum Ghodoussipour, Dr. Vignesh Packiam
What matters most to patients with non-muscle invasive bladder cancer (NMIBC)? In this episode of BackTable Urology,...
900+ listens
Tumor Board Case
Jun 24, 2025
with Dr. Nirmish Singla, Dr. Jeannie Hoffman-Censits and Dr. Bogdana Schmidt
Tumor Board Case
Jun 24, 2025
with Dr. Nirmish Singla, Dr. Jeannie Hoffman-Censits and Dr. Bogdana Schmidt
Tumor Board Case
Jun 17, 2025
with Dr. Juanita Crook, Dr. Andrea Apolo and Dr. Charles Peyton
Tumor Board Case
Jun 17, 2025
with Dr. Juanita Crook, Dr. Andrea Apolo and Dr. Charles Peyton
Tumor Board Case
Jun 24, 2025
with Dr. Nirmish Singla, Dr. Jeannie Hoffman-Censits and Dr. Bogdana Schmidt
Tumor Board Case
Jun 24, 2025
with Dr. Nirmish Singla, Dr. Jeannie Hoffman-Censits and Dr. Bogdana Schmidt
Tumor Board Case
Jun 17, 2025
with Dr. Juanita Crook, Dr. Andrea Apolo and Dr. Charles Peyton
Tumor Board Case
Jun 17, 2025
with Dr. Juanita Crook, Dr. Andrea Apolo and Dr. Charles Peyton
Urology Course
3 hours, 28 lessons
The Materials available on BackTable are provided for informational and educational purposes only and are not a substitute for the independent professional judgment of a qualified healthcare professional in diagnosing or treating patients. Any opinions, statements, or views expressed are those of the individual contributors and do not necessarily reflect those of the publisher, platform, or any affiliated organization.